nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS3—systemic lupus erythematosus	0.275	1	CbGaD
Doxorubicin—NOS2—Dexamethasone—systemic lupus erythematosus	0.055	0.128	CbGbCtD
Doxorubicin—XDH—Azathioprine—systemic lupus erythematosus	0.0486	0.113	CbGbCtD
Doxorubicin—ABCC10—Cyclosporine—systemic lupus erythematosus	0.0367	0.0853	CbGbCtD
Doxorubicin—ABCC3—Cyclosporine—systemic lupus erythematosus	0.0231	0.0536	CbGbCtD
Doxorubicin—ABCG2—Leflunomide—systemic lupus erythematosus	0.0202	0.0471	CbGbCtD
Doxorubicin—ABCB11—Cyclosporine—systemic lupus erythematosus	0.0199	0.0463	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—systemic lupus erythematosus	0.0194	0.0451	CbGbCtD
Doxorubicin—ABCC1—Cyclosporine—systemic lupus erythematosus	0.0142	0.0329	CbGbCtD
Doxorubicin—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.0138	0.0322	CbGbCtD
Doxorubicin—ABCB11—Dexamethasone—systemic lupus erythematosus	0.0131	0.0305	CbGbCtD
Doxorubicin—CYP1B1—Dexamethasone—systemic lupus erythematosus	0.0131	0.0305	CbGbCtD
Doxorubicin—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0125	0.0291	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—systemic lupus erythematosus	0.0122	0.0284	CbGbCtD
Doxorubicin—ABCC2—Cyclosporine—systemic lupus erythematosus	0.0105	0.0244	CbGbCtD
Doxorubicin—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.01	0.0233	CbGbCtD
Doxorubicin—ABCG2—Cyclosporine—systemic lupus erythematosus	0.00948	0.022	CbGbCtD
Doxorubicin—ABCC1—Methotrexate—systemic lupus erythematosus	0.00749	0.0174	CbGbCtD
Doxorubicin—ABCC2—Dexamethasone—systemic lupus erythematosus	0.0069	0.016	CbGbCtD
Doxorubicin—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00624	0.0145	CbGbCtD
Doxorubicin—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00595	0.0138	CbGbCtD
Doxorubicin—ABCC2—Methotrexate—systemic lupus erythematosus	0.00555	0.0129	CbGbCtD
Doxorubicin—ABCG2—Methotrexate—systemic lupus erythematosus	0.00502	0.0117	CbGbCtD
Doxorubicin—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00451	0.0105	CbGbCtD
Doxorubicin—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.00439	0.0102	CbGbCtD
Doxorubicin—ABCB1—Betamethasone—systemic lupus erythematosus	0.00387	0.00899	CbGbCtD
Doxorubicin—ABCB1—Prednisolone—systemic lupus erythematosus	0.00382	0.00887	CbGbCtD
Doxorubicin—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00362	0.00841	CbGbCtD
Doxorubicin—ABCB1—Prednisone—systemic lupus erythematosus	0.0036	0.00838	CbGbCtD
Doxorubicin—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00356	0.00829	CbGbCtD
Doxorubicin—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00342	0.00794	CbGbCtD
Doxorubicin—NOS3—tunica intima—systemic lupus erythematosus	0.00336	0.0426	CbGeAlD
Doxorubicin—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00322	0.00749	CbGbCtD
Doxorubicin—CYP3A4—Dapsone—systemic lupus erythematosus	0.00312	0.00724	CbGbCtD
Doxorubicin—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0027	0.00628	CbGbCtD
Doxorubicin—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0027	0.00628	CbGbCtD
Doxorubicin—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00232	0.00539	CbGbCtD
Doxorubicin—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00229	0.00532	CbGbCtD
Doxorubicin—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00225	0.00523	CbGbCtD
Doxorubicin—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00217	0.00504	CbGbCtD
Doxorubicin—CYP3A4—Prednisone—systemic lupus erythematosus	0.00216	0.00502	CbGbCtD
Doxorubicin—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00212	0.00493	CbGbCtD
Doxorubicin—NOS3—umbilical vein—systemic lupus erythematosus	0.00205	0.026	CbGeAlD
Doxorubicin—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00205	0.00476	CbGbCtD
Doxorubicin—ABCB1—Methotrexate—systemic lupus erythematosus	0.00181	0.0042	CbGbCtD
Doxorubicin—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00135	0.00313	CbGbCtD
Doxorubicin—NOS1—endothelium—systemic lupus erythematosus	0.00128	0.0162	CbGeAlD
Doxorubicin—SLC22A16—kidney—systemic lupus erythematosus	0.00118	0.0149	CbGeAlD
Doxorubicin—NOS2—tendon—systemic lupus erythematosus	0.00115	0.0145	CbGeAlD
Doxorubicin—ABCC6—blood plasma—systemic lupus erythematosus	0.00103	0.0131	CbGeAlD
Doxorubicin—NOS3—endothelium—systemic lupus erythematosus	0.000973	0.0123	CbGeAlD
Doxorubicin—YWHAG—blood plasma—systemic lupus erythematosus	0.000972	0.0123	CbGeAlD
Doxorubicin—SLC22A16—bone marrow—systemic lupus erythematosus	0.000919	0.0116	CbGeAlD
Doxorubicin—ABCB8—kidney—systemic lupus erythematosus	0.000914	0.0116	CbGeAlD
Doxorubicin—RALBP1—blood plasma—systemic lupus erythematosus	0.000878	0.0111	CbGeAlD
Doxorubicin—NOS3—blood plasma—systemic lupus erythematosus	0.000864	0.0109	CbGeAlD
Doxorubicin—AKR1A1—nephron tubule—systemic lupus erythematosus	0.000773	0.00979	CbGeAlD
Doxorubicin—NDUFS7—connective tissue—systemic lupus erythematosus	0.000725	0.00918	CbGeAlD
Doxorubicin—AKR1A1—skin of body—systemic lupus erythematosus	0.000721	0.00912	CbGeAlD
Doxorubicin—CBR3—tendon—systemic lupus erythematosus	0.000711	0.00899	CbGeAlD
Doxorubicin—NDUFS7—nephron tubule—systemic lupus erythematosus	0.000703	0.0089	CbGeAlD
Doxorubicin—AKR1A1—kidney—systemic lupus erythematosus	0.000679	0.0086	CbGeAlD
Doxorubicin—AKR1A1—cortex of kidney—systemic lupus erythematosus	0.000662	0.00838	CbGeAlD
Doxorubicin—ABCB8—lung—systemic lupus erythematosus	0.000648	0.0082	CbGeAlD
Doxorubicin—CBR3—lung—systemic lupus erythematosus	0.000624	0.00789	CbGeAlD
Doxorubicin—NDUFS7—kidney—systemic lupus erythematosus	0.000617	0.00782	CbGeAlD
Doxorubicin—NDUFS7—cortex of kidney—systemic lupus erythematosus	0.000601	0.00761	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—systemic lupus erythematosus	0.000601	0.00761	CbGeAlD
Doxorubicin—ABCB8—nervous system—systemic lupus erythematosus	0.0006	0.00759	CbGeAlD
Doxorubicin—NDUFS3—connective tissue—systemic lupus erythematosus	0.000594	0.00752	CbGeAlD
Doxorubicin—ABCC3—blood plasma—systemic lupus erythematosus	0.000589	0.00746	CbGeAlD
Doxorubicin—AURKA—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.000589	0.2	CbGdCrCtD
Doxorubicin—AKR1A1—lymphoid tissue—systemic lupus erythematosus	0.000584	0.00739	CbGeAlD
Doxorubicin—NDUFS2—nephron tubule—systemic lupus erythematosus	0.000582	0.00737	CbGeAlD
Doxorubicin—ABCB8—central nervous system—systemic lupus erythematosus	0.000578	0.00731	CbGeAlD
Doxorubicin—CBR3—nervous system—systemic lupus erythematosus	0.000577	0.00731	CbGeAlD
Doxorubicin—NDUFS3—nephron tubule—systemic lupus erythematosus	0.000575	0.00728	CbGeAlD
Doxorubicin—AURKA—kidney—systemic lupus erythematosus	0.000574	0.00727	CbGeAlD
Doxorubicin—CBR3—central nervous system—systemic lupus erythematosus	0.000556	0.00704	CbGeAlD
Doxorubicin—ABCC6—connective tissue—systemic lupus erythematosus	0.00055	0.00696	CbGeAlD
Doxorubicin—AKR1A1—tendon—systemic lupus erythematosus	0.000549	0.00694	CbGeAlD
Doxorubicin—DHCR7—nephron tubule—systemic lupus erythematosus	0.000546	0.00692	CbGeAlD
Doxorubicin—NDUFS2—skin of body—systemic lupus erythematosus	0.000543	0.00687	CbGeAlD
Doxorubicin—NDUFS3—skin of body—systemic lupus erythematosus	0.000536	0.00679	CbGeAlD
Doxorubicin—AKR1A1—bone marrow—systemic lupus erythematosus	0.000531	0.00673	CbGeAlD
Doxorubicin—YWHAG—connective tissue—systemic lupus erythematosus	0.000518	0.00655	CbGeAlD
Doxorubicin—NOS1—kidney—systemic lupus erythematosus	0.000515	0.00652	CbGeAlD
Doxorubicin—NDUFS2—kidney—systemic lupus erythematosus	0.000512	0.00648	CbGeAlD
Doxorubicin—DHCR7—skin of body—systemic lupus erythematosus	0.000509	0.00645	CbGeAlD
Doxorubicin—NDUFS3—kidney—systemic lupus erythematosus	0.000505	0.0064	CbGeAlD
Doxorubicin—NOS1—cortex of kidney—systemic lupus erythematosus	0.000501	0.00635	CbGeAlD
Doxorubicin—NDUFS7—tendon—systemic lupus erythematosus	0.000499	0.00631	CbGeAlD
Doxorubicin—NDUFS2—cortex of kidney—systemic lupus erythematosus	0.000498	0.00631	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—systemic lupus erythematosus	0.000493	0.00624	CbGeAlD
Doxorubicin—NDUFS3—cortex of kidney—systemic lupus erythematosus	0.000492	0.00623	CbGeAlD
Doxorubicin—NDUFS7—bone marrow—systemic lupus erythematosus	0.000483	0.00611	CbGeAlD
Doxorubicin—AKR1A1—lung—systemic lupus erythematosus	0.000481	0.00609	CbGeAlD
Doxorubicin—ABCC6—kidney—systemic lupus erythematosus	0.000468	0.00592	CbGeAlD
Doxorubicin—DHCR7—cortex of kidney—systemic lupus erythematosus	0.000468	0.00592	CbGeAlD
Doxorubicin—AURKA—tendon—systemic lupus erythematosus	0.000464	0.00587	CbGeAlD
Doxorubicin—NOS3—connective tissue—systemic lupus erythematosus	0.00046	0.00582	CbGeAlD
Doxorubicin—CYP3A4—urine—systemic lupus erythematosus	0.000458	0.0058	CbGeAlD
Doxorubicin—RALBP1—nephron tubule—systemic lupus erythematosus	0.000453	0.00573	CbGeAlD
Doxorubicin—CYP2D6—urine—systemic lupus erythematosus	0.000451	0.00571	CbGeAlD
Doxorubicin—AURKA—bone marrow—systemic lupus erythematosus	0.000449	0.00568	CbGeAlD
Doxorubicin—AKR1A1—nervous system—systemic lupus erythematosus	0.000446	0.00564	CbGeAlD
Doxorubicin—YWHAG—kidney—systemic lupus erythematosus	0.000441	0.00558	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—systemic lupus erythematosus	0.000439	0.00556	CbGeAlD
Doxorubicin—NDUFS7—lung—systemic lupus erythematosus	0.000438	0.00554	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—systemic lupus erythematosus	0.000434	0.0055	CbGeAlD
Doxorubicin—XDH—kidney—systemic lupus erythematosus	0.00043	0.00544	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—systemic lupus erythematosus	0.000429	0.00543	CbGeAlD
Doxorubicin—YWHAG—cortex of kidney—systemic lupus erythematosus	0.000429	0.00543	CbGeAlD
Doxorubicin—CBR1—nephron tubule—systemic lupus erythematosus	0.000423	0.00535	CbGeAlD
Doxorubicin—AKR1C3—nephron tubule—systemic lupus erythematosus	0.000417	0.00529	CbGeAlD
Doxorubicin—NOS1—tendon—systemic lupus erythematosus	0.000416	0.00526	CbGeAlD
Doxorubicin—NDUFS2—tendon—systemic lupus erythematosus	0.000413	0.00523	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—systemic lupus erythematosus	0.000412	0.00522	CbGeAlD
Doxorubicin—NDUFS3—tendon—systemic lupus erythematosus	0.000408	0.00517	CbGeAlD
Doxorubicin—AURKA—lung—systemic lupus erythematosus	0.000407	0.00515	CbGeAlD
Doxorubicin—NDUFS7—nervous system—systemic lupus erythematosus	0.000405	0.00513	CbGeAlD
Doxorubicin—NDUFS2—bone marrow—systemic lupus erythematosus	0.0004	0.00507	CbGeAlD
Doxorubicin—RALBP1—kidney—systemic lupus erythematosus	0.000398	0.00504	CbGeAlD
Doxorubicin—NDUFS3—bone marrow—systemic lupus erythematosus	0.000395	0.005	CbGeAlD
Doxorubicin—CBR1—skin of body—systemic lupus erythematosus	0.000394	0.00499	CbGeAlD
Doxorubicin—NOS3—kidney—systemic lupus erythematosus	0.000391	0.00496	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—systemic lupus erythematosus	0.00039	0.00494	CbGeAlD
Doxorubicin—RALBP1—cortex of kidney—systemic lupus erythematosus	0.000388	0.00491	CbGeAlD
Doxorubicin—POR—nephron tubule—systemic lupus erythematosus	0.000381	0.00483	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—systemic lupus erythematosus	0.000378	0.00479	CbGeAlD
Doxorubicin—AURKA—nervous system—systemic lupus erythematosus	0.000377	0.00477	CbGeAlD
Doxorubicin—DHCR7—bone marrow—systemic lupus erythematosus	0.000376	0.00475	CbGeAlD
Doxorubicin—CBR1—kidney—systemic lupus erythematosus	0.000371	0.0047	CbGeAlD
Doxorubicin—NOS1—lung—systemic lupus erythematosus	0.000365	0.00462	CbGeAlD
Doxorubicin—AURKA—central nervous system—systemic lupus erythematosus	0.000363	0.00459	CbGeAlD
Doxorubicin—NDUFS2—lung—systemic lupus erythematosus	0.000363	0.00459	CbGeAlD
Doxorubicin—CBR1—cortex of kidney—systemic lupus erythematosus	0.000362	0.00458	CbGeAlD
Doxorubicin—NDUFS3—lung—systemic lupus erythematosus	0.000358	0.00453	CbGeAlD
Doxorubicin—AKR1C3—cortex of kidney—systemic lupus erythematosus	0.000357	0.00452	CbGeAlD
Doxorubicin—YWHAG—tendon—systemic lupus erythematosus	0.000356	0.0045	CbGeAlD
Doxorubicin—NQO1—connective tissue—systemic lupus erythematosus	0.00035	0.00443	CbGeAlD
Doxorubicin—YWHAG—bone marrow—systemic lupus erythematosus	0.000345	0.00436	CbGeAlD
Doxorubicin—DHCR7—lung—systemic lupus erythematosus	0.00034	0.00431	CbGeAlD
Doxorubicin—NQO1—nephron tubule—systemic lupus erythematosus	0.000339	0.00429	CbGeAlD
Doxorubicin—NOS1—nervous system—systemic lupus erythematosus	0.000338	0.00428	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—systemic lupus erythematosus	0.000336	0.00426	CbGeAlD
Doxorubicin—NDUFS2—nervous system—systemic lupus erythematosus	0.000336	0.00425	CbGeAlD
Doxorubicin—NDUFS3—nervous system—systemic lupus erythematosus	0.000332	0.0042	CbGeAlD
Doxorubicin—ABCC6—lung—systemic lupus erythematosus	0.000332	0.0042	CbGeAlD
Doxorubicin—POR—cortex of kidney—systemic lupus erythematosus	0.000326	0.00413	CbGeAlD
Doxorubicin—NOS1—central nervous system—systemic lupus erythematosus	0.000325	0.00412	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—systemic lupus erythematosus	0.000323	0.00409	CbGeAlD
Doxorubicin—RALBP1—tendon—systemic lupus erythematosus	0.000321	0.00407	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—systemic lupus erythematosus	0.000319	0.00404	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—systemic lupus erythematosus	0.000319	0.00404	CbGeAlD
Doxorubicin—CYP2B6—blood plasma—systemic lupus erythematosus	0.000317	0.00401	CbGeAlD
Doxorubicin—NOS3—tendon—systemic lupus erythematosus	0.000316	0.004	CbGeAlD
Doxorubicin—NQO1—skin of body—systemic lupus erythematosus	0.000316	0.004	CbGeAlD
Doxorubicin—DHCR7—nervous system—systemic lupus erythematosus	0.000315	0.00399	CbGeAlD
Doxorubicin—YWHAG—lung—systemic lupus erythematosus	0.000312	0.00395	CbGeAlD
Doxorubicin—RALBP1—bone marrow—systemic lupus erythematosus	0.000311	0.00394	CbGeAlD
Doxorubicin—DHCR7—central nervous system—systemic lupus erythematosus	0.000303	0.00384	CbGeAlD
Doxorubicin—CBR1—tendon—systemic lupus erythematosus	0.0003	0.0038	CbGeAlD
Doxorubicin—NQO1—kidney—systemic lupus erythematosus	0.000298	0.00377	CbGeAlD
Doxorubicin—AKR1C3—tendon—systemic lupus erythematosus	0.000296	0.00375	CbGeAlD
Doxorubicin—CBR1—bone marrow—systemic lupus erythematosus	0.000291	0.00368	CbGeAlD
Doxorubicin—NQO1—cortex of kidney—systemic lupus erythematosus	0.00029	0.00367	CbGeAlD
Doxorubicin—YWHAG—nervous system—systemic lupus erythematosus	0.000289	0.00366	CbGeAlD
Doxorubicin—AKR1C3—bone marrow—systemic lupus erythematosus	0.000287	0.00363	CbGeAlD
Doxorubicin—RALBP1—lung—systemic lupus erythematosus	0.000282	0.00357	CbGeAlD
Doxorubicin—YWHAG—central nervous system—systemic lupus erythematosus	0.000278	0.00352	CbGeAlD
Doxorubicin—NOS3—lung—systemic lupus erythematosus	0.000277	0.00351	CbGeAlD
Doxorubicin—POR—tendon—systemic lupus erythematosus	0.00027	0.00342	CbGeAlD
Doxorubicin—ABCC3—kidney—systemic lupus erythematosus	0.000267	0.00338	CbGeAlD
Doxorubicin—ABCC10—kidney—systemic lupus erythematosus	0.000266	0.00337	CbGeAlD
Doxorubicin—CBR1—lung—systemic lupus erythematosus	0.000263	0.00333	CbGeAlD
Doxorubicin—POR—bone marrow—systemic lupus erythematosus	0.000262	0.00332	CbGeAlD
Doxorubicin—RALBP1—nervous system—systemic lupus erythematosus	0.000261	0.00331	CbGeAlD
Doxorubicin—AKR1C3—lung—systemic lupus erythematosus	0.00026	0.00329	CbGeAlD
Doxorubicin—ABCC10—cortex of kidney—systemic lupus erythematosus	0.000259	0.00328	CbGeAlD
Doxorubicin—NOS3—nervous system—systemic lupus erythematosus	0.000257	0.00325	CbGeAlD
Doxorubicin—TOP2A—tendon—systemic lupus erythematosus	0.000252	0.00319	CbGeAlD
Doxorubicin—RALBP1—central nervous system—systemic lupus erythematosus	0.000251	0.00318	CbGeAlD
Doxorubicin—NOS3—central nervous system—systemic lupus erythematosus	0.000247	0.00313	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—systemic lupus erythematosus	0.000246	0.00311	CbGeAlD
Doxorubicin—TOP2A—bone marrow—systemic lupus erythematosus	0.000244	0.00309	CbGeAlD
Doxorubicin—CBR1—nervous system—systemic lupus erythematosus	0.000244	0.00309	CbGeAlD
Doxorubicin—ABCC2—nephron tubule—systemic lupus erythematosus	0.000243	0.00307	CbGeAlD
Doxorubicin—NQO1—tendon—systemic lupus erythematosus	0.00024	0.00304	CbGeAlD
Doxorubicin—CYP3A4—blood plasma—systemic lupus erythematosus	0.000239	0.00303	CbGeAlD
Doxorubicin—CYP1B1—nephron tubule—systemic lupus erythematosus	0.000238	0.00301	CbGeAlD
Doxorubicin—POR—lung—systemic lupus erythematosus	0.000237	0.00301	CbGeAlD
Doxorubicin—CYP2D6—blood plasma—systemic lupus erythematosus	0.000235	0.00298	CbGeAlD
Doxorubicin—CBR1—central nervous system—systemic lupus erythematosus	0.000235	0.00297	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—systemic lupus erythematosus	0.000228	0.00289	CbGeAlD
Doxorubicin—CYP1B1—skin of body—systemic lupus erythematosus	0.000222	0.00281	CbGeAlD
Doxorubicin—TOP2A—lung—systemic lupus erythematosus	0.000221	0.0028	CbGeAlD
Doxorubicin—ABCC10—tendon—systemic lupus erythematosus	0.000215	0.00272	CbGeAlD
Doxorubicin—ABCC2—kidney—systemic lupus erythematosus	0.000213	0.0027	CbGeAlD
Doxorubicin—NQO1—lung—systemic lupus erythematosus	0.000211	0.00267	CbGeAlD
Doxorubicin—CYP1B1—kidney—systemic lupus erythematosus	0.000209	0.00265	CbGeAlD
Doxorubicin—ABCC10—bone marrow—systemic lupus erythematosus	0.000208	0.00263	CbGeAlD
Doxorubicin—ABCC2—cortex of kidney—systemic lupus erythematosus	0.000208	0.00263	CbGeAlD
Doxorubicin—CYP1B1—cortex of kidney—systemic lupus erythematosus	0.000204	0.00258	CbGeAlD
Doxorubicin—NQO1—nervous system—systemic lupus erythematosus	0.000195	0.00247	CbGeAlD
Doxorubicin—ABCC3—lung—systemic lupus erythematosus	0.000189	0.0024	CbGeAlD
Doxorubicin—ABCC10—lung—systemic lupus erythematosus	0.000188	0.00238	CbGeAlD
Doxorubicin—NQO1—central nervous system—systemic lupus erythematosus	0.000188	0.00238	CbGeAlD
Doxorubicin—ABCC1—cortex of kidney—systemic lupus erythematosus	0.000183	0.00232	CbGeAlD
Doxorubicin—CYP1B1—lymphoid tissue—systemic lupus erythematosus	0.00018	0.00227	CbGeAlD
Doxorubicin—ABCG2—nephron tubule—systemic lupus erythematosus	0.000177	0.00224	CbGeAlD
Doxorubicin—ABCC3—nervous system—systemic lupus erythematosus	0.000175	0.00222	CbGeAlD
Doxorubicin—ABCC2—tendon—systemic lupus erythematosus	0.000172	0.00218	CbGeAlD
Doxorubicin—ABCB1—blood plasma—systemic lupus erythematosus	0.000169	0.00214	CbGeAlD
Doxorubicin—CYP1B1—tendon—systemic lupus erythematosus	0.000169	0.00214	CbGeAlD
Doxorubicin—ABCC3—central nervous system—systemic lupus erythematosus	0.000169	0.00214	CbGeAlD
Doxorubicin—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000163	0.00207	CbGeAlD
Doxorubicin—CYP2B6—skin of body—systemic lupus erythematosus	0.000152	0.00193	CbGeAlD
Doxorubicin—ABCC1—tendon—systemic lupus erythematosus	0.000152	0.00192	CbGeAlD
Doxorubicin—CYP1B1—lung—systemic lupus erythematosus	0.000148	0.00187	CbGeAlD
Doxorubicin—CYP2B6—kidney—systemic lupus erythematosus	0.000144	0.00182	CbGeAlD
Doxorubicin—CYP1B1—nervous system—systemic lupus erythematosus	0.000137	0.00174	CbGeAlD
Doxorubicin—ABCC1—lung—systemic lupus erythematosus	0.000133	0.00169	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—systemic lupus erythematosus	0.000132	0.00167	CbGeAlD
Doxorubicin—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000123	0.00156	CbGeAlD
Doxorubicin—ABCG2—bone marrow—systemic lupus erythematosus	0.000122	0.00154	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Hydrocortisone—systemic lupus erythematosus	0.000121	0.0409	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Methylprednisolone—systemic lupus erythematosus	0.000114	0.0386	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Dexamethasone—systemic lupus erythematosus	0.000112	0.038	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Betamethasone—systemic lupus erythematosus	0.000112	0.038	CbGdCrCtD
Doxorubicin—ABCG2—lung—systemic lupus erythematosus	0.00011	0.0014	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Triamcinolone—systemic lupus erythematosus	0.00011	0.0371	CbGdCrCtD
Doxorubicin—CYP3A4—kidney—systemic lupus erythematosus	0.000108	0.00137	CbGeAlD
Doxorubicin—CYP2D6—kidney—systemic lupus erythematosus	0.000107	0.00135	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Prednisone—systemic lupus erythematosus	0.000104	0.0352	CbGdCrCtD
Doxorubicin—CYP2B6—lung—systemic lupus erythematosus	0.000102	0.00129	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Prednisolone—systemic lupus erythematosus	0.000101	0.0344	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Hydrocortisone—systemic lupus erythematosus	9.98e-05	0.0338	CbGdCrCtD
Doxorubicin—CYP2B6—nervous system—systemic lupus erythematosus	9.42e-05	0.00119	CbGeAlD
Doxorubicin—CBR3—Triamcinolone—Methylprednisolone—systemic lupus erythematosus	9.41e-05	0.0319	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Betamethasone—systemic lupus erythematosus	9.27e-05	0.0314	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Dexamethasone—systemic lupus erythematosus	9.27e-05	0.0314	CbGdCrCtD
Doxorubicin—CYP2B6—central nervous system—systemic lupus erythematosus	9.07e-05	0.00115	CbGeAlD
Doxorubicin—ABCB1—nephron tubule—systemic lupus erythematosus	8.73e-05	0.00111	CbGeAlD
Doxorubicin—CBR3—Fluocinolone Acetonide—Methylprednisolone—systemic lupus erythematosus	8.65e-05	0.0293	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisone—systemic lupus erythematosus	8.59e-05	0.0291	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Betamethasone—systemic lupus erythematosus	8.51e-05	0.0288	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Dexamethasone—systemic lupus erythematosus	8.51e-05	0.0288	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisolone—systemic lupus erythematosus	8.39e-05	0.0284	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Triamcinolone—systemic lupus erythematosus	8.32e-05	0.0282	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Prednisolone—systemic lupus erythematosus	7.71e-05	0.0261	CbGdCrCtD
Doxorubicin—ABCB1—kidney—systemic lupus erythematosus	7.68e-05	0.000972	CbGeAlD
Doxorubicin—ABCB1—cortex of kidney—systemic lupus erythematosus	7.47e-05	0.000946	CbGeAlD
Doxorubicin—CYP3A4—nervous system—systemic lupus erythematosus	7.11e-05	0.000901	CbGeAlD
Doxorubicin—CYP2D6—nervous system—systemic lupus erythematosus	7e-05	0.000886	CbGeAlD
Doxorubicin—CYP3A4—central nervous system—systemic lupus erythematosus	6.85e-05	0.000867	CbGeAlD
Doxorubicin—CYP2D6—central nervous system—systemic lupus erythematosus	6.74e-05	0.000853	CbGeAlD
Doxorubicin—ABCB1—lymphoid tissue—systemic lupus erythematosus	6.59e-05	0.000835	CbGeAlD
Doxorubicin—ABCB1—bone marrow—systemic lupus erythematosus	6e-05	0.00076	CbGeAlD
Doxorubicin—ABCB1—lung—systemic lupus erythematosus	5.44e-05	0.000688	CbGeAlD
Doxorubicin—ABCB1—nervous system—systemic lupus erythematosus	5.04e-05	0.000638	CbGeAlD
Doxorubicin—CBR3—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	4.93e-05	0.0167	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Hydrocortisone—systemic lupus erythematosus	4.93e-05	0.0167	CbGdCrCtD
Doxorubicin—ABCB1—central nervous system—systemic lupus erythematosus	4.85e-05	0.000614	CbGeAlD
Doxorubicin—CBR3—Betamethasone—Methylprednisolone—systemic lupus erythematosus	4.65e-05	0.0158	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	4.65e-05	0.0158	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Betamethasone—systemic lupus erythematosus	4.58e-05	0.0155	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Dexamethasone—systemic lupus erythematosus	4.58e-05	0.0155	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Triamcinolone—systemic lupus erythematosus	4.47e-05	0.0152	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Triamcinolone—systemic lupus erythematosus	4.47e-05	0.0152	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisone—systemic lupus erythematosus	4.25e-05	0.0144	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisone—systemic lupus erythematosus	4.25e-05	0.0144	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisolone—systemic lupus erythematosus	4.15e-05	0.014	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisolone—systemic lupus erythematosus	4.15e-05	0.014	CbGdCrCtD
Doxorubicin—Oedema—Betamethasone—systemic lupus erythematosus	2.99e-05	0.000199	CcSEcCtD
Doxorubicin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	2.99e-05	0.000199	CcSEcCtD
Doxorubicin—Oedema—Dexamethasone—systemic lupus erythematosus	2.99e-05	0.000199	CcSEcCtD
Doxorubicin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	2.99e-05	0.000199	CcSEcCtD
Doxorubicin—Insomnia—Triamcinolone—systemic lupus erythematosus	2.98e-05	0.000198	CcSEcCtD
Doxorubicin—Insomnia—Methylprednisolone—systemic lupus erythematosus	2.97e-05	0.000198	CcSEcCtD
Doxorubicin—Infection—Dexamethasone—systemic lupus erythematosus	2.97e-05	0.000198	CcSEcCtD
Doxorubicin—Infection—Betamethasone—systemic lupus erythematosus	2.97e-05	0.000198	CcSEcCtD
Doxorubicin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	2.96e-05	0.000197	CcSEcCtD
Doxorubicin—Paraesthesia—Triamcinolone—systemic lupus erythematosus	2.96e-05	0.000197	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	2.95e-05	0.000196	CcSEcCtD
Doxorubicin—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	2.95e-05	0.000196	CcSEcCtD
Doxorubicin—Visual impairment—Methotrexate—systemic lupus erythematosus	2.95e-05	0.000196	CcSEcCtD
Doxorubicin—Anaemia—Prednisone—systemic lupus erythematosus	2.95e-05	0.000196	CcSEcCtD
Doxorubicin—Shock—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000196	CcSEcCtD
Doxorubicin—Shock—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000196	CcSEcCtD
Doxorubicin—Dyspnoea—Triamcinolone—systemic lupus erythematosus	2.94e-05	0.000195	CcSEcCtD
Doxorubicin—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	2.93e-05	0.000195	CcSEcCtD
Doxorubicin—Nervous system disorder—Betamethasone—systemic lupus erythematosus	2.93e-05	0.000195	CcSEcCtD
Doxorubicin—Agitation—Prednisone—systemic lupus erythematosus	2.93e-05	0.000195	CcSEcCtD
Doxorubicin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	2.93e-05	0.000195	CcSEcCtD
Doxorubicin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	2.93e-05	0.000195	CcSEcCtD
Doxorubicin—Tachycardia—Dexamethasone—systemic lupus erythematosus	2.92e-05	0.000194	CcSEcCtD
Doxorubicin—Tachycardia—Betamethasone—systemic lupus erythematosus	2.92e-05	0.000194	CcSEcCtD
Doxorubicin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	2.9e-05	0.000193	CcSEcCtD
Doxorubicin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	2.9e-05	0.000193	CcSEcCtD
Doxorubicin—Erythema multiforme—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000193	CcSEcCtD
Doxorubicin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	2.9e-05	0.000193	CcSEcCtD
Doxorubicin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	2.89e-05	0.000192	CcSEcCtD
Doxorubicin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	2.89e-05	0.000192	CcSEcCtD
Doxorubicin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	2.88e-05	0.000192	CcSEcCtD
Doxorubicin—Malaise—Prednisone—systemic lupus erythematosus	2.88e-05	0.000191	CcSEcCtD
Doxorubicin—Vertigo—Prednisone—systemic lupus erythematosus	2.87e-05	0.000191	CcSEcCtD
Doxorubicin—Eye disorder—Methotrexate—systemic lupus erythematosus	2.86e-05	0.00019	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	2.86e-05	0.00019	CcSEcCtD
Doxorubicin—Syncope—Prednisone—systemic lupus erythematosus	2.86e-05	0.00019	CcSEcCtD
Doxorubicin—Tinnitus—Methotrexate—systemic lupus erythematosus	2.86e-05	0.00019	CcSEcCtD
Doxorubicin—Anorexia—Dexamethasone—systemic lupus erythematosus	2.85e-05	0.00019	CcSEcCtD
Doxorubicin—Anorexia—Betamethasone—systemic lupus erythematosus	2.85e-05	0.00019	CcSEcCtD
Doxorubicin—Urticaria—Prednisolone—systemic lupus erythematosus	2.85e-05	0.000189	CcSEcCtD
Doxorubicin—Cardiac disorder—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000189	CcSEcCtD
Doxorubicin—Fatigue—Triamcinolone—systemic lupus erythematosus	2.84e-05	0.000189	CcSEcCtD
Doxorubicin—Fatigue—Methylprednisolone—systemic lupus erythematosus	2.84e-05	0.000189	CcSEcCtD
Doxorubicin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	2.83e-05	0.000188	CcSEcCtD
Doxorubicin—Asthenia—Cyclosporine—systemic lupus erythematosus	2.83e-05	0.000188	CcSEcCtD
Doxorubicin—Pain—Triamcinolone—systemic lupus erythematosus	2.82e-05	0.000187	CcSEcCtD
Doxorubicin—Loss of consciousness—Prednisone—systemic lupus erythematosus	2.81e-05	0.000187	CcSEcCtD
Doxorubicin—Hypotension—Dexamethasone—systemic lupus erythematosus	2.79e-05	0.000186	CcSEcCtD
Doxorubicin—Hypotension—Betamethasone—systemic lupus erythematosus	2.79e-05	0.000186	CcSEcCtD
Doxorubicin—Pruritus—Cyclosporine—systemic lupus erythematosus	2.79e-05	0.000185	CcSEcCtD
Doxorubicin—Urticaria—Hydrocortisone—systemic lupus erythematosus	2.78e-05	0.000185	CcSEcCtD
Doxorubicin—Angiopathy—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000185	CcSEcCtD
Doxorubicin—Immune system disorder—Methotrexate—systemic lupus erythematosus	2.77e-05	0.000184	CcSEcCtD
Doxorubicin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	2.77e-05	0.000184	CcSEcCtD
Doxorubicin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	2.77e-05	0.000184	CcSEcCtD
Doxorubicin—Convulsion—Prednisone—systemic lupus erythematosus	2.77e-05	0.000184	CcSEcCtD
Doxorubicin—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000184	CcSEcCtD
Doxorubicin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	2.76e-05	0.000183	CcSEcCtD
Doxorubicin—Hypertension—Prednisone—systemic lupus erythematosus	2.76e-05	0.000183	CcSEcCtD
Doxorubicin—Chills—Methotrexate—systemic lupus erythematosus	2.75e-05	0.000183	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	2.73e-05	0.000181	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	2.73e-05	0.000181	CcSEcCtD
Doxorubicin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	2.72e-05	0.000181	CcSEcCtD
Doxorubicin—Myalgia—Prednisone—systemic lupus erythematosus	2.72e-05	0.000181	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—systemic lupus erythematosus	2.72e-05	0.000181	CcSEcCtD
Doxorubicin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	2.72e-05	0.000181	CcSEcCtD
Doxorubicin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	2.71e-05	0.00018	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—systemic lupus erythematosus	2.71e-05	0.00018	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—systemic lupus erythematosus	2.71e-05	0.00018	CcSEcCtD
Doxorubicin—Insomnia—Betamethasone—systemic lupus erythematosus	2.71e-05	0.00018	CcSEcCtD
Doxorubicin—Insomnia—Dexamethasone—systemic lupus erythematosus	2.71e-05	0.00018	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	2.7e-05	0.000179	CcSEcCtD
Doxorubicin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	2.7e-05	0.000179	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	2.69e-05	0.000179	CcSEcCtD
Doxorubicin—Paraesthesia—Dexamethasone—systemic lupus erythematosus	2.69e-05	0.000179	CcSEcCtD
Doxorubicin—Paraesthesia—Betamethasone—systemic lupus erythematosus	2.69e-05	0.000179	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—systemic lupus erythematosus	2.68e-05	0.000179	CcSEcCtD
Doxorubicin—Mental disorder—Methotrexate—systemic lupus erythematosus	2.68e-05	0.000179	CcSEcCtD
Doxorubicin—Erythema—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000177	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000177	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	2.64e-05	0.000176	CcSEcCtD
Doxorubicin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	2.63e-05	0.000175	CcSEcCtD
Doxorubicin—Dyspepsia—Betamethasone—systemic lupus erythematosus	2.63e-05	0.000175	CcSEcCtD
Doxorubicin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	2.63e-05	0.000175	CcSEcCtD
Doxorubicin—Urticaria—Triamcinolone—systemic lupus erythematosus	2.62e-05	0.000174	CcSEcCtD
Doxorubicin—Urticaria—Methylprednisolone—systemic lupus erythematosus	2.61e-05	0.000174	CcSEcCtD
Doxorubicin—Dysgeusia—Methotrexate—systemic lupus erythematosus	2.61e-05	0.000174	CcSEcCtD
Doxorubicin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	2.61e-05	0.000173	CcSEcCtD
Doxorubicin—Dizziness—Cyclosporine—systemic lupus erythematosus	2.6e-05	0.000173	CcSEcCtD
Doxorubicin—Oedema—Prednisone—systemic lupus erythematosus	2.6e-05	0.000173	CcSEcCtD
Doxorubicin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	2.6e-05	0.000173	CcSEcCtD
Doxorubicin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	2.6e-05	0.000173	CcSEcCtD
Doxorubicin—Decreased appetite—Betamethasone—systemic lupus erythematosus	2.6e-05	0.000173	CcSEcCtD
Doxorubicin—Decreased appetite—Dexamethasone—systemic lupus erythematosus	2.6e-05	0.000173	CcSEcCtD
Doxorubicin—Infection—Prednisone—systemic lupus erythematosus	2.59e-05	0.000172	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	2.58e-05	0.000172	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	2.58e-05	0.000172	CcSEcCtD
Doxorubicin—Back pain—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000172	CcSEcCtD
Doxorubicin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	2.58e-05	0.000172	CcSEcCtD
Doxorubicin—Fatigue—Betamethasone—systemic lupus erythematosus	2.58e-05	0.000172	CcSEcCtD
Doxorubicin—Fatigue—Dexamethasone—systemic lupus erythematosus	2.58e-05	0.000172	CcSEcCtD
Doxorubicin—Shock—Prednisone—systemic lupus erythematosus	2.56e-05	0.00017	CcSEcCtD
Doxorubicin—Pain—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.00017	CcSEcCtD
Doxorubicin—Pain—Betamethasone—systemic lupus erythematosus	2.56e-05	0.00017	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—systemic lupus erythematosus	2.55e-05	0.00017	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—systemic lupus erythematosus	2.54e-05	0.000169	CcSEcCtD
Doxorubicin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.54e-05	0.000169	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—systemic lupus erythematosus	2.53e-05	0.000168	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	2.52e-05	0.000167	CcSEcCtD
Doxorubicin—Vision blurred—Methotrexate—systemic lupus erythematosus	2.51e-05	0.000167	CcSEcCtD
Doxorubicin—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.51e-05	0.000167	CcSEcCtD
Doxorubicin—Vomiting—Cyclosporine—systemic lupus erythematosus	2.5e-05	0.000167	CcSEcCtD
Doxorubicin—Rash—Cyclosporine—systemic lupus erythematosus	2.48e-05	0.000165	CcSEcCtD
Doxorubicin—Anorexia—Prednisone—systemic lupus erythematosus	2.48e-05	0.000165	CcSEcCtD
Doxorubicin—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.48e-05	0.000165	CcSEcCtD
Doxorubicin—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.48e-05	0.000165	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	2.47e-05	0.000165	CcSEcCtD
Doxorubicin—Headache—Cyclosporine—systemic lupus erythematosus	2.47e-05	0.000164	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—systemic lupus erythematosus	2.47e-05	0.000164	CcSEcCtD
Doxorubicin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	2.46e-05	0.000164	CcSEcCtD
Doxorubicin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	2.46e-05	0.000164	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.45e-05	0.000163	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.45e-05	0.000163	CcSEcCtD
Doxorubicin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.44e-05	0.000163	CcSEcCtD
Doxorubicin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	2.43e-05	0.000162	CcSEcCtD
Doxorubicin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.42e-05	0.000161	CcSEcCtD
Doxorubicin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.42e-05	0.000161	CcSEcCtD
Doxorubicin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.42e-05	0.000161	CcSEcCtD
Doxorubicin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.41e-05	0.00016	CcSEcCtD
Doxorubicin—Malaise—Methotrexate—systemic lupus erythematosus	2.41e-05	0.00016	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000159	CcSEcCtD
Doxorubicin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.4e-05	0.000159	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—systemic lupus erythematosus	2.39e-05	0.000159	CcSEcCtD
Doxorubicin—Urticaria—Dexamethasone—systemic lupus erythematosus	2.38e-05	0.000158	CcSEcCtD
Doxorubicin—Urticaria—Betamethasone—systemic lupus erythematosus	2.38e-05	0.000158	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.37e-05	0.000158	CcSEcCtD
Doxorubicin—Dizziness—Prednisolone—systemic lupus erythematosus	2.37e-05	0.000158	CcSEcCtD
Doxorubicin—Asthenia—Triamcinolone—systemic lupus erythematosus	2.37e-05	0.000157	CcSEcCtD
Doxorubicin—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.36e-05	0.000157	CcSEcCtD
Doxorubicin—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.36e-05	0.000157	CcSEcCtD
Doxorubicin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.36e-05	0.000157	CcSEcCtD
Doxorubicin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.36e-05	0.000157	CcSEcCtD
Doxorubicin—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.36e-05	0.000157	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—systemic lupus erythematosus	2.36e-05	0.000157	CcSEcCtD
Doxorubicin—Nausea—Cyclosporine—systemic lupus erythematosus	2.34e-05	0.000156	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—systemic lupus erythematosus	2.34e-05	0.000156	CcSEcCtD
Doxorubicin—Pruritus—Triamcinolone—systemic lupus erythematosus	2.33e-05	0.000155	CcSEcCtD
Doxorubicin—Cough—Methotrexate—systemic lupus erythematosus	2.33e-05	0.000155	CcSEcCtD
Doxorubicin—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.33e-05	0.000155	CcSEcCtD
Doxorubicin—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.32e-05	0.000154	CcSEcCtD
Doxorubicin—Convulsion—Methotrexate—systemic lupus erythematosus	2.31e-05	0.000154	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—systemic lupus erythematosus	2.29e-05	0.000153	CcSEcCtD
Doxorubicin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.28e-05	0.000152	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000151	CcSEcCtD
Doxorubicin—Chest pain—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000151	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000151	CcSEcCtD
Doxorubicin—Decreased appetite—Prednisone—systemic lupus erythematosus	2.26e-05	0.000151	CcSEcCtD
Doxorubicin—Rash—Prednisolone—systemic lupus erythematosus	2.26e-05	0.00015	CcSEcCtD
Doxorubicin—Dermatitis—Prednisolone—systemic lupus erythematosus	2.26e-05	0.00015	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.26e-05	0.00015	CcSEcCtD
Doxorubicin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.25e-05	0.00015	CcSEcCtD
Doxorubicin—Fatigue—Prednisone—systemic lupus erythematosus	2.25e-05	0.000149	CcSEcCtD
Doxorubicin—Headache—Prednisolone—systemic lupus erythematosus	2.25e-05	0.000149	CcSEcCtD
Doxorubicin—Discomfort—Methotrexate—systemic lupus erythematosus	2.24e-05	0.000149	CcSEcCtD
Doxorubicin—Constipation—Prednisone—systemic lupus erythematosus	2.23e-05	0.000148	CcSEcCtD
Doxorubicin—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.23e-05	0.000148	CcSEcCtD
Doxorubicin—Rash—Hydrocortisone—systemic lupus erythematosus	2.21e-05	0.000147	CcSEcCtD
Doxorubicin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.21e-05	0.000147	CcSEcCtD
Doxorubicin—Confusional state—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000146	CcSEcCtD
Doxorubicin—Headache—Hydrocortisone—systemic lupus erythematosus	2.19e-05	0.000146	CcSEcCtD
Doxorubicin—Dizziness—Triamcinolone—systemic lupus erythematosus	2.18e-05	0.000145	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.18e-05	0.000145	CcSEcCtD
Doxorubicin—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.17e-05	0.000145	CcSEcCtD
Doxorubicin—Infection—Methotrexate—systemic lupus erythematosus	2.16e-05	0.000144	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Hydrocortisone—systemic lupus erythematosus	2.15e-05	0.00728	CbGdCrCtD
Doxorubicin—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.15e-05	0.000143	CcSEcCtD
Doxorubicin—Asthenia—Betamethasone—systemic lupus erythematosus	2.15e-05	0.000143	CcSEcCtD
Doxorubicin—Asthenia—Dexamethasone—systemic lupus erythematosus	2.15e-05	0.000143	CcSEcCtD
Doxorubicin—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.13e-05	0.000142	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.13e-05	0.000142	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.13e-05	0.000142	CcSEcCtD
Doxorubicin—Nausea—Prednisolone—systemic lupus erythematosus	2.13e-05	0.000142	CcSEcCtD
Doxorubicin—Pruritus—Betamethasone—systemic lupus erythematosus	2.12e-05	0.000141	CcSEcCtD
Doxorubicin—Pruritus—Dexamethasone—systemic lupus erythematosus	2.12e-05	0.000141	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—systemic lupus erythematosus	2.11e-05	0.000141	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.1e-05	0.00014	CcSEcCtD
Doxorubicin—Vomiting—Triamcinolone—systemic lupus erythematosus	2.1e-05	0.000139	CcSEcCtD
Doxorubicin—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.09e-05	0.000139	CcSEcCtD
Doxorubicin—Nausea—Hydrocortisone—systemic lupus erythematosus	2.08e-05	0.000138	CcSEcCtD
Doxorubicin—Rash—Triamcinolone—systemic lupus erythematosus	2.08e-05	0.000138	CcSEcCtD
Doxorubicin—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.08e-05	0.000138	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—systemic lupus erythematosus	2.08e-05	0.000138	CcSEcCtD
Doxorubicin—Rash—Methylprednisolone—systemic lupus erythematosus	2.07e-05	0.000138	CcSEcCtD
Doxorubicin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.07e-05	0.000138	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—systemic lupus erythematosus	2.07e-05	0.000138	CcSEcCtD
Doxorubicin—Headache—Triamcinolone—systemic lupus erythematosus	2.07e-05	0.000137	CcSEcCtD
Doxorubicin—Headache—Methylprednisolone—systemic lupus erythematosus	2.06e-05	0.000137	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—systemic lupus erythematosus	2.06e-05	0.000137	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—systemic lupus erythematosus	2.06e-05	0.000137	CcSEcCtD
Doxorubicin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.05e-05	0.000136	CcSEcCtD
Doxorubicin—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.05e-05	0.000136	CcSEcCtD
Doxorubicin—Hypotension—Methotrexate—systemic lupus erythematosus	2.03e-05	0.000135	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	1.98e-05	0.000132	CcSEcCtD
Doxorubicin—Dizziness—Dexamethasone—systemic lupus erythematosus	1.98e-05	0.000132	CcSEcCtD
Doxorubicin—Dizziness—Betamethasone—systemic lupus erythematosus	1.98e-05	0.000132	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—systemic lupus erythematosus	1.97e-05	0.000131	CcSEcCtD
Doxorubicin—Nausea—Triamcinolone—systemic lupus erythematosus	1.96e-05	0.00013	CcSEcCtD
Doxorubicin—Paraesthesia—Methotrexate—systemic lupus erythematosus	1.95e-05	0.00013	CcSEcCtD
Doxorubicin—Nausea—Methylprednisolone—systemic lupus erythematosus	1.95e-05	0.00013	CcSEcCtD
Doxorubicin—Dyspnoea—Methotrexate—systemic lupus erythematosus	1.94e-05	0.000129	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—systemic lupus erythematosus	1.94e-05	0.000129	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisone—systemic lupus erythematosus	1.92e-05	0.000128	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—systemic lupus erythematosus	1.92e-05	0.000127	CcSEcCtD
Doxorubicin—Vomiting—Dexamethasone—systemic lupus erythematosus	1.9e-05	0.000126	CcSEcCtD
Doxorubicin—Vomiting—Betamethasone—systemic lupus erythematosus	1.9e-05	0.000126	CcSEcCtD
Doxorubicin—Decreased appetite—Methotrexate—systemic lupus erythematosus	1.89e-05	0.000126	CcSEcCtD
Doxorubicin—Rash—Betamethasone—systemic lupus erythematosus	1.89e-05	0.000125	CcSEcCtD
Doxorubicin—Rash—Dexamethasone—systemic lupus erythematosus	1.89e-05	0.000125	CcSEcCtD
Doxorubicin—Dermatitis—Betamethasone—systemic lupus erythematosus	1.88e-05	0.000125	CcSEcCtD
Doxorubicin—Dermatitis—Dexamethasone—systemic lupus erythematosus	1.88e-05	0.000125	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000125	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000125	CcSEcCtD
Doxorubicin—Headache—Betamethasone—systemic lupus erythematosus	1.87e-05	0.000125	CcSEcCtD
Doxorubicin—Headache—Dexamethasone—systemic lupus erythematosus	1.87e-05	0.000125	CcSEcCtD
Doxorubicin—Asthenia—Prednisone—systemic lupus erythematosus	1.87e-05	0.000124	CcSEcCtD
Doxorubicin—Pain—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000124	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—systemic lupus erythematosus	1.85e-05	0.00627	CbGdCrCtD
Doxorubicin—Pruritus—Prednisone—systemic lupus erythematosus	1.84e-05	0.000123	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisolone—systemic lupus erythematosus	1.81e-05	0.00612	CbGdCrCtD
Doxorubicin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	1.79e-05	0.000119	CcSEcCtD
Doxorubicin—Diarrhoea—Prednisone—systemic lupus erythematosus	1.78e-05	0.000119	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	1.78e-05	0.000118	CcSEcCtD
Doxorubicin—Nausea—Betamethasone—systemic lupus erythematosus	1.78e-05	0.000118	CcSEcCtD
Doxorubicin—Nausea—Dexamethasone—systemic lupus erythematosus	1.78e-05	0.000118	CcSEcCtD
Doxorubicin—Urticaria—Methotrexate—systemic lupus erythematosus	1.73e-05	0.000115	CcSEcCtD
Doxorubicin—Dizziness—Prednisone—systemic lupus erythematosus	1.72e-05	0.000115	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—systemic lupus erythematosus	1.72e-05	0.000114	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—systemic lupus erythematosus	1.72e-05	0.000114	CcSEcCtD
Doxorubicin—Vomiting—Prednisone—systemic lupus erythematosus	1.66e-05	0.00011	CcSEcCtD
Doxorubicin—Rash—Prednisone—systemic lupus erythematosus	1.64e-05	0.000109	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—systemic lupus erythematosus	1.64e-05	0.000109	CcSEcCtD
Doxorubicin—Headache—Prednisone—systemic lupus erythematosus	1.63e-05	0.000109	CcSEcCtD
Doxorubicin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	1.6e-05	0.000107	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—systemic lupus erythematosus	1.56e-05	0.000104	CcSEcCtD
Doxorubicin—Nausea—Prednisone—systemic lupus erythematosus	1.55e-05	0.000103	CcSEcCtD
Doxorubicin—Pruritus—Methotrexate—systemic lupus erythematosus	1.54e-05	0.000102	CcSEcCtD
Doxorubicin—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.49e-05	9.91e-05	CcSEcCtD
Doxorubicin—Dizziness—Methotrexate—systemic lupus erythematosus	1.44e-05	9.58e-05	CcSEcCtD
Doxorubicin—TOP2A—Norethindrone—Hydrocortisone—systemic lupus erythematosus	1.4e-05	0.00475	CbGdCrCtD
Doxorubicin—Vomiting—Methotrexate—systemic lupus erythematosus	1.38e-05	9.21e-05	CcSEcCtD
Doxorubicin—Rash—Methotrexate—systemic lupus erythematosus	1.37e-05	9.13e-05	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—systemic lupus erythematosus	1.37e-05	9.12e-05	CcSEcCtD
Doxorubicin—Headache—Methotrexate—systemic lupus erythematosus	1.36e-05	9.07e-05	CcSEcCtD
Doxorubicin—Nausea—Methotrexate—systemic lupus erythematosus	1.29e-05	8.6e-05	CcSEcCtD
Doxorubicin—AKR1C3—Disease—JAK1—systemic lupus erythematosus	1.21e-05	0.000193	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HIST2H2AC—systemic lupus erythematosus	1.21e-05	0.000193	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.2e-05	0.000192	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—RXRA—systemic lupus erythematosus	1.2e-05	0.000192	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CD80—systemic lupus erythematosus	1.19e-05	0.00019	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—EP300—systemic lupus erythematosus	1.18e-05	0.000189	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—EP300—systemic lupus erythematosus	1.18e-05	0.000189	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CSK—systemic lupus erythematosus	1.17e-05	0.000188	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.17e-05	0.000187	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.17e-05	0.000187	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.16e-05	0.000186	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—NOS3—systemic lupus erythematosus	1.16e-05	0.000185	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TGFB1—systemic lupus erythematosus	1.16e-05	0.000185	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL2—systemic lupus erythematosus	1.15e-05	0.000184	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.15e-05	0.000184	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JUNB—systemic lupus erythematosus	1.15e-05	0.000183	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TYK2—systemic lupus erythematosus	1.15e-05	0.000183	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CCR5—systemic lupus erythematosus	1.14e-05	0.000183	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTGS2—systemic lupus erythematosus	1.14e-05	0.000181	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NOS3—systemic lupus erythematosus	1.12e-05	0.00018	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.12e-05	0.000179	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—RXRA—systemic lupus erythematosus	1.12e-05	0.000178	CbGpPWpGaD
Doxorubicin—TOP2A—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	1.11e-05	0.00378	CbGdCrCtD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.11e-05	0.000178	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—EP300—systemic lupus erythematosus	1.11e-05	0.000178	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.1e-05	0.000176	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD247—systemic lupus erythematosus	1.1e-05	0.000176	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NAT2—systemic lupus erythematosus	1.1e-05	0.000176	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.09e-05	0.000175	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.09e-05	0.000174	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.08e-05	0.000172	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NCF2—systemic lupus erythematosus	1.07e-05	0.000172	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NAT2—systemic lupus erythematosus	1.07e-05	0.000171	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.06e-05	0.000169	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—systemic lupus erythematosus	1.06e-05	0.000169	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PRL—systemic lupus erythematosus	1.06e-05	0.000169	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.05e-05	0.000168	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—systemic lupus erythematosus	1.04e-05	0.000165	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—EP300—systemic lupus erythematosus	1.03e-05	0.000165	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—systemic lupus erythematosus	1.03e-05	0.000164	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD80—systemic lupus erythematosus	1.02e-05	0.000163	CbGpPWpGaD
Doxorubicin—NOS3—Disease—JAK1—systemic lupus erythematosus	1.02e-05	0.000163	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—RXRA—systemic lupus erythematosus	1.02e-05	0.000162	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.01e-05	0.000161	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.01e-05	0.000161	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TYK2—systemic lupus erythematosus	1e-05	0.00016	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.87e-06	0.000158	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NOS3—systemic lupus erythematosus	9.85e-06	0.000157	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—VEGFA—systemic lupus erythematosus	9.8e-06	0.000157	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN1B—systemic lupus erythematosus	9.79e-06	0.000156	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CDKN1B—systemic lupus erythematosus	9.74e-06	0.000156	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	9.71e-06	0.000155	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JUNB—systemic lupus erythematosus	9.69e-06	0.000155	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CCR5—systemic lupus erythematosus	9.66e-06	0.000154	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	9.61e-06	0.000154	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.57e-06	0.000153	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—EP300—systemic lupus erythematosus	9.45e-06	0.000151	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD80—systemic lupus erythematosus	9.41e-06	0.00015	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	9.21e-06	0.000147	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.19e-06	0.000147	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN1A—systemic lupus erythematosus	9.03e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—systemic lupus erythematosus	8.99e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CDKN1A—systemic lupus erythematosus	8.99e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PRL—systemic lupus erythematosus	8.93e-06	0.000143	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—EP300—systemic lupus erythematosus	8.81e-06	0.000141	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.81e-06	0.000141	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.77e-06	0.00014	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TYK2—systemic lupus erythematosus	8.64e-06	0.000138	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—EP300—systemic lupus erythematosus	8.6e-06	0.000137	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EP300—systemic lupus erythematosus	8.55e-06	0.000137	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.53e-06	0.000136	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.49e-06	0.000136	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NOS3—systemic lupus erythematosus	8.48e-06	0.000135	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JAK1—systemic lupus erythematosus	8.45e-06	0.000135	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—JUNB—systemic lupus erythematosus	8.43e-06	0.000135	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—systemic lupus erythematosus	8.35e-06	0.000133	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—RXRA—systemic lupus erythematosus	8.24e-06	0.000132	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR5—systemic lupus erythematosus	8.01e-06	0.000128	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD80—systemic lupus erythematosus	7.95e-06	0.000127	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TYK2—systemic lupus erythematosus	7.94e-06	0.000127	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MMP9—systemic lupus erythematosus	7.9e-06	0.000126	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—RXRA—systemic lupus erythematosus	7.9e-06	0.000126	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.89e-06	0.000126	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.89e-06	0.000126	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.87e-06	0.000126	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PPARG—systemic lupus erythematosus	7.87e-06	0.000126	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	7.86e-06	0.000126	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—C3—systemic lupus erythematosus	7.82e-06	0.000125	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—systemic lupus erythematosus	7.81e-06	0.000125	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS3—systemic lupus erythematosus	7.79e-06	0.000124	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PRL—systemic lupus erythematosus	7.77e-06	0.000124	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—systemic lupus erythematosus	7.76e-06	0.000124	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.64e-06	0.000122	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.63e-06	0.000122	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.59e-06	0.000121	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PPARG—systemic lupus erythematosus	7.59e-06	0.000121	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.5e-06	0.00012	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EP300—systemic lupus erythematosus	7.49e-06	0.00012	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	7.45e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—systemic lupus erythematosus	7.43e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDKN1B—systemic lupus erythematosus	7.35e-06	0.000117	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.33e-06	0.000117	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—systemic lupus erythematosus	7.18e-06	0.000115	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JAK1—systemic lupus erythematosus	7.14e-06	0.000114	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—systemic lupus erythematosus	7.13e-06	0.000114	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NAT2—systemic lupus erythematosus	7.12e-06	0.000114	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.1e-06	0.000113	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—systemic lupus erythematosus	7.07e-06	0.000113	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PPARG—systemic lupus erythematosus	7.05e-06	0.000113	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.9e-06	0.00011	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.87e-06	0.00011	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—F2—systemic lupus erythematosus	6.87e-06	0.00011	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—systemic lupus erythematosus	6.82e-06	0.000109	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDKN1A—systemic lupus erythematosus	6.78e-06	0.000108	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR5—systemic lupus erythematosus	6.77e-06	0.000108	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NOS3—systemic lupus erythematosus	6.76e-06	0.000108	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN1B—systemic lupus erythematosus	6.75e-06	0.000108	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TYK2—systemic lupus erythematosus	6.71e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.67e-06	0.000107	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.67e-06	0.000106	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—C3—systemic lupus erythematosus	6.61e-06	0.000106	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.6e-06	0.000105	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD80—systemic lupus erythematosus	6.59e-06	0.000105	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.54e-06	0.000104	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NOS3—systemic lupus erythematosus	6.53e-06	0.000104	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.51e-06	0.000104	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EP300—systemic lupus erythematosus	6.45e-06	0.000103	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PPARG—systemic lupus erythematosus	6.41e-06	0.000102	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—systemic lupus erythematosus	6.34e-06	0.000101	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.29e-06	0.0001	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN1A—systemic lupus erythematosus	6.23e-06	9.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—JAK1—systemic lupus erythematosus	6.21e-06	9.92e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.19e-06	9.89e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—RXRA—systemic lupus erythematosus	6.19e-06	9.88e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—systemic lupus erythematosus	6.19e-06	9.88e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL2—systemic lupus erythematosus	6.12e-06	9.78e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NOS3—systemic lupus erythematosus	6.07e-06	9.69e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—systemic lupus erythematosus	6.07e-06	9.69e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—systemic lupus erythematosus	6.02e-06	9.62e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—RXRA—systemic lupus erythematosus	5.98e-06	9.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—systemic lupus erythematosus	5.97e-06	9.53e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EP300—systemic lupus erythematosus	5.93e-06	9.47e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—systemic lupus erythematosus	5.89e-06	9.4e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—F2—systemic lupus erythematosus	5.8e-06	9.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—systemic lupus erythematosus	5.77e-06	9.21e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.74e-06	9.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN1B—systemic lupus erythematosus	5.7e-06	9.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.68e-06	9.08e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—systemic lupus erythematosus	5.61e-06	8.96e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—systemic lupus erythematosus	5.6e-06	8.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD80—systemic lupus erythematosus	5.56e-06	8.89e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TYK2—systemic lupus erythematosus	5.56e-06	8.88e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.55e-06	8.87e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—systemic lupus erythematosus	5.55e-06	8.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOS3—systemic lupus erythematosus	5.46e-06	8.72e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	5.44e-06	8.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.31e-06	8.48e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN1A—systemic lupus erythematosus	5.26e-06	8.41e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	5.25e-06	8.39e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—systemic lupus erythematosus	5.2e-06	8.31e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—systemic lupus erythematosus	5.17e-06	8.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—systemic lupus erythematosus	5.15e-06	8.23e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—EP300—systemic lupus erythematosus	5.15e-06	8.22e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—systemic lupus erythematosus	5.04e-06	8.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EP300—systemic lupus erythematosus	5.01e-06	8e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—systemic lupus erythematosus	4.99e-06	7.96e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—EP300—systemic lupus erythematosus	4.96e-06	7.93e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	4.95e-06	7.9e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—systemic lupus erythematosus	4.91e-06	7.84e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD80—systemic lupus erythematosus	4.84e-06	7.73e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.73e-06	7.55e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TYK2—systemic lupus erythematosus	4.7e-06	7.5e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—systemic lupus erythematosus	4.68e-06	7.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—systemic lupus erythematosus	4.63e-06	7.39e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—EP300—systemic lupus erythematosus	4.62e-06	7.37e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—systemic lupus erythematosus	4.48e-06	7.16e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NOS3—systemic lupus erythematosus	4.47e-06	7.14e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—systemic lupus erythematosus	4.38e-06	6.99e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.36e-06	6.97e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—systemic lupus erythematosus	4.35e-06	6.95e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NOS3—systemic lupus erythematosus	4.29e-06	6.85e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—systemic lupus erythematosus	4.23e-06	6.75e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—EP300—systemic lupus erythematosus	4.19e-06	6.7e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EP300—systemic lupus erythematosus	4.15e-06	6.63e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—systemic lupus erythematosus	4.09e-06	6.53e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TYK2—systemic lupus erythematosus	4.09e-06	6.53e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—systemic lupus erythematosus	4.01e-06	6.41e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.99e-06	6.38e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	3.99e-06	6.37e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.93e-06	6.28e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—systemic lupus erythematosus	3.92e-06	6.26e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—systemic lupus erythematosus	3.91e-06	6.24e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—systemic lupus erythematosus	3.91e-06	6.24e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—systemic lupus erythematosus	3.88e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—systemic lupus erythematosus	3.78e-06	6.04e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—systemic lupus erythematosus	3.7e-06	5.91e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—systemic lupus erythematosus	3.7e-06	5.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.69e-06	5.89e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—systemic lupus erythematosus	3.67e-06	5.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.61e-06	5.76e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.57e-06	5.7e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—systemic lupus erythematosus	3.51e-06	5.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EP300—systemic lupus erythematosus	3.51e-06	5.6e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1B—systemic lupus erythematosus	3.48e-06	5.55e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	3.44e-06	5.49e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—EP300—systemic lupus erythematosus	3.4e-06	5.43e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—systemic lupus erythematosus	3.4e-06	5.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—systemic lupus erythematosus	3.36e-06	5.37e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.32e-06	5.31e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—systemic lupus erythematosus	3.28e-06	5.24e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—EP300—systemic lupus erythematosus	3.26e-06	5.21e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—systemic lupus erythematosus	3.25e-06	5.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.24e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1A—systemic lupus erythematosus	3.21e-06	5.12e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—systemic lupus erythematosus	3.09e-06	4.94e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—systemic lupus erythematosus	3.07e-06	4.91e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EP300—systemic lupus erythematosus	3.05e-06	4.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.05e-06	4.87e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—systemic lupus erythematosus	2.97e-06	4.75e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	2.96e-06	4.72e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	2.94e-06	4.7e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.77e-06	4.43e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—systemic lupus erythematosus	2.72e-06	4.34e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	2.7e-06	4.32e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—systemic lupus erythematosus	2.65e-06	4.24e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—EP300—systemic lupus erythematosus	2.56e-06	4.08e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	2.52e-06	4.03e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—EP300—systemic lupus erythematosus	2.47e-06	3.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—systemic lupus erythematosus	2.3e-06	3.67e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	2.27e-06	3.62e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.25e-06	3.59e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	2.17e-06	3.46e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—systemic lupus erythematosus	2e-06	3.19e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	1.98e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.86e-06	2.97e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.81e-06	2.9e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.75e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.67e-06	2.67e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	1.65e-06	2.63e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.6e-06	2.55e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.57e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.51e-06	2.41e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.46e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.38e-06	2.2e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.22e-06	1.94e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.15e-06	1.83e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.15e-06	1.83e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.03e-06	1.64e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	9.85e-07	1.57e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	9.01e-07	1.44e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.49e-07	1.2e-05	CbGpPWpGaD
